An epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: The Grenada heart project, 2005-2007

Preventing Chronic Disease

Volumn 9, Issue 4, 2012, Pages

  Block, Robert C ^a   Dozier, Ann M ^b   Hazel Fernandez, Leslie ^c   Guido, Joseph J ^b   Pearson, Thomas A ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c Competitive Health Analytics Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMMUNITY CARE; CROSS-SECTIONAL STUDY; FEEDING BEHAVIOR; FEMALE; GRENADA; HEALTH EDUCATION; HEALTH PROMOTION; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; OBESITY; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMMUNITY NETWORKS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; FOOD HABITS; GRENADA; HEALTH EDUCATION; HEALTH PROMOTION; HUMANS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 84864862422     PISSN: 15451151     EISSN: 21665435     Source Type: Journal    
DOI: 10.5888/pcd9.110167     Document Type: Article

References (34)

1. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change.1971. Milbank Q 2005;83(4):731-57.
2. Dozier AM, Block R, Levy D, Dye TD, Pearson TA. Cardiovascular health in the developing world: community perceptions from Carriacou, Grenada. CVD Prev Control 2008;3(3):123-31.
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104(22):2746-53.
4. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases - where worlds meet. N Engl J Med 2010;363(13):1196-8.
5. Akinkugbe OO, Nicholson GD, Cruickshank JK. Heart disease in blacks of Africa and the Caribbean. Cardiovasc Clin 1991;21(3):377-91.
6. Razvi SS, Srikanth S. One WHO STEPS Stroke tool for all settings? Lancet Neurol 2007;6(5):386-7; author reply 388-9.
7. Carey M, Markham C, Gaffney P, Boran C, Maher V. Validation of a point of care lipid analyser using a hospital based reference laboratory. Ir J Med Sci 2006;175(4):30-5.
8. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109(3):433-8.
9. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health; 2002. p. V-14-V-15. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf. Accessed January 30, 2012.
10. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in prevalence, treatment, and control of hypertension-United States, 1999-2002. MMWR Morb Mortal Wkly Rep 2005;54(1):7-9.
11. Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 2001;49(2):109-16.
12. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008;197(2):821-8.
13. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106(21):2747-57.
14. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354(9177):447-55.
15. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the Cardiovascular Health Study. Circulation 2006;114(3):209-15.
16. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003;77(2):319-25.
17. Saito Y, Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Ishikawa Y, et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis 2008;200(1):135-40.
18. GISSI HF, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, doubleblind, placebo-controlled trial. Lancet 2008;372(9645):1223-30.
19. Kennedy A, Martinez K, Chuang CC, LaPoint K, McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 2009;139(1):1-4.
20. Ruidavets JB, Bongard V, Dallongeville J, Arveiler D, Ducimetière P, Perret B, et al. High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome. J Epidemiol Community Health 2007;61(9):810-7.
21. Panagiotakos DB, Pitsavos C, Skoumas Y, Stefanadis C. The association between food patterns and the metabolic syndrome using principal components analysis: the ATTICA Study. J Am Diet Assoc 2007;107(6):979-87.
22. Blaha MJ, Bansal S, Rouf R, Golden SH, Blumenthal RS, Defilippis AP. A practical "ABCDE" approach to the metabolic syndrome. Mayo Clin Proc 2008;83(8):932-41.
23. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369(9567):1090-8.
24. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93(11 Suppl):S9-30.
25. Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L, et al. Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull World Health Organ 2006;84(6):461-9.
26. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003;61(1):29-37.
27. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365(9468):1398-405.
28. Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F. Prevalence of cardiovascular risk factors in a middleincome country and estimated cost of a treatment strategy. BMC Public Health 2006;6:9.
29. Tappy L, Bovet P, Shamlaye C. Prevalence of diabetes and obesity in the adult population of the Seychelles. Diabet Med 1991;8(5):448-52.
30. Ghosh A. Effects of socio-economic and behavioural characteristics in explaining central obesity - a study on adult Asian Indians in Calcutta, India. Coll Antropol 2006;30(2):265-71.
31. Al-Nozha MM, Al-Hazzaa HM, Arafah MR, Al-Khadra A, Al-Mazrou YY, Al-Maatouq MA, et al. Prevalence of physical activity and inactivity among Saudis aged 30-70 years. A population-based cross-sectional study. Saudi Med J 2007;28(4):559-68.
32. Flynn KJ, Fitzgibbon M. Body images and obesity risk among black females: a review of the literature. Ann Behav Med 1998;20(1):13-24.
33. Kumanyika S, Wilson JF, Guilford-Davenport M. Weight-related attitudes and behaviors of black women. J Am Diet Assoc 1993;93(4):416-22.
34. Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition 34. 2007;23(9):696-708.